Semler Scientific, Inc.
SMLR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.08 | -0.01 | 0.00 | 0.01 |
| FCF Yield | -7.39% | 0.10% | -0.55% | -26.24% |
| EV / EBITDA | 21.57 | -276.30 | -5.88 | 116.75 |
| Quality | ||||
| ROIC | -0.65% | -0.35% | -10.42% | 1.36% |
| Gross Margin | 91.51% | 91.01% | 89.39% | 91.12% |
| Cash Conversion Ratio | -1.95 | 0.01 | 0.03 | 0.25 |
| Growth | ||||
| Revenue 3-Year CAGR | -17.96% | -12.73% | -6.84% | -0.23% |
| Free Cash Flow Growth | -7,484.75% | 123.40% | 98.33% | -5,563.73% |
| Safety | ||||
| Net Debt / EBITDA | 4.15 | -42.59 | -1.17 | -2.40 |
| Interest Coverage | -3.42 | -1.79 | -32.98 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 1.31 | 1.32 | 2.53 | 3.08 |
| Cash Conversion Cycle | 71.06 | 79.97 | 10.84 | 49.55 |